Clean the site, pinch a fold of skin, insert the needle at 90 degrees, deliver the dose slowly, count to six before withdrawing, and use a different spot within the same area next week
Targeted therapies: a new generation of cancer treatments
Adults with obesity (BMI 30) or with overweight (BMI 27) plus at least one weight-related condition such as type 2 diabetes, hypertension or dyslipidaemia
The Healthon Weight Loss Program offers two highly effective GLP-1 medications: Semaglutide (Generic Ozempic/Wegovy): A GLP-1 receptor agonist, FDA-approved for weight management and type 2 diabetes
We explore the intricate dynamics shaping the prescribing landscape for these powerful medications
This cardiovascular benefit was observed across diverse patient populations and appears to extend beyond glucose control effects